SM
Summit Midstream Partners, LP (SMLP)·Q4 2023 Earnings Summary
Executive Summary
- Q4 2023 delivered sequential growth with total revenues of $127.3M, adjusted EBITDA of $75.0M, DCF of $37.8M, and FCF of $20.4M; full-year adjusted EBITDA was $266.8M and management framed Q4 run-rate at ~$300M adjusted EBITDA .
- Management advanced its strategic alternatives review, citing “advanced stages” and strong third-party interest (asset sales to partnership-level transactions); 2024 adjusted EBITDA guidance was set at $260–$300M and capex at $30–$40M .
- Operations were solid: throughput increased across natural gas and Double E, while oil-price driven segments posted $30.3M segment EBITDA; DJ Basin de-bottlenecking and Utica compression projects started, supporting incremental fees and ~$5M 2024 synergies .
- Liquidity remained adequate with $14.0M cash and $82.7M ABL availability; total leverage ~5.4x, first lien leverage 1.2x, interest coverage 1.93x, all covenants in compliance .
- Distribution suspension continued on common and Series A preferred; near-term stock catalysts include strategic review outcomes, Double E commercialization, and execution vs 2024 guidance .
What Went Well and What Went Wrong
-
What Went Well
- Strong Q4 operational execution: adjusted EBITDA rose to $75.0M; Double E volumes increased 18% q/q to 386 MMcf/d with new 40 MMcf/d 10-year take-or-pay contract supporting Janus Plant connection .
- Strategic/procedural wins: DJ Basin de-bottlenecking commissioned with ~$5M synergy expected in 2024; new 25,500-acre OGC dedication in Utica; incremental compression fee to begin in Q1 2024 behind SMU .
- Management confidence and process update: “We believe the strategic review process is entering advanced stages” (CEO Heath Deneke), narrowing alternatives to maximize unitholder value .
-
What Went Wrong
- Continued commodity price headwinds: lower realized commodity prices in the DJ basin negatively impacted EBITDA by ~$2.0M q/q in Q4 .
- Barnett segment softness: adjusted EBITDA decreased $0.3M q/q due to ~$0.4M higher OpEx and ongoing customer volume curtailments (~20 MMcf/d) .
- Elevated interest burden and non-GAAP adjustments: interest expense in Q4 was $36.8M and loss on early extinguishment of debt was $10.9M, weighing on GAAP net income (Q4 net loss of $15.1M) .
Financial Results
*Values retrieved from S&P Global were unavailable due to mapping limitations.
Segment adjusted EBITDA ($USD Thousands):
Operational KPIs (average daily throughput):
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Summit delivered solid fourth quarter 2023 financial and operating results representing run-rate Adjusted EBITDA of $300 million. It has been a very busy quarter, advancing a range of strategic alternatives and executing several key commercial milestones.” — Heath Deneke, CEO .
- “We believe the strategic review process is entering advanced stages… narrowing the range of alternatives with the goal of maximizing value for the Partnership’s unitholders.” — Heath Deneke .
- “We recently commissioned our DJ Basin de-bottlenecking projects… extract approximately $5 million of synergies in 2024… executed a new 40 MMcf/d 10-year take-or-pay contract… connecting a new 300 MMcf/d processing plant.” — Heath Deneke .
- “We announced 2024 adjusted EBITDA guidance range of $260 million to $300 million… despite [commodity price] volatility… we remain encouraged with the long-term prospects for SMLP.” — Heath Deneke .
Q&A Highlights
- Analysts focused on the strategic alternatives timeline and scope; management indicated the process was in late/advanced stages with multiple pathways (asset-level and partnership-level), maintaining focus on maximizing unitholder value .
- Clarifications around Double E contract economics and Janus Plant connection indicated supportive returns on ~$6.0M connection cost ($4.2M net to SMLP) and positioning for incremental contracts as upstream volumes ramp .
- Discussion on 2024 guidance drivers underscored conservative risking for well timing and commodity price volatility; volume growth visibility supported by five rigs and >140 DUCs .
- Near-term operational catalysts highlighted: Utica compression fees starting in Q1 2024 and DJ Basin synergy capture, contributing to EBITDA trajectory .
Estimates Context
- Wall Street consensus (S&P Global) for Q4 2023 EPS and revenue was unavailable due to a mapping limitation; as such, we cannot present formal consensus comparisons at this time.*
- Given Q4 outcomes (revenue $127.3M; adjusted EBITDA $75.0M), near-term estimate revisions may focus on: (1) Double E contracted step-up to 1,020 MMcf/d in Nov 2024, (2) synergy realization in DJ (~$5M in 2024), (3) incremental compression revenue in Utica, and (4) commodity price risk embedded in guidance .
*Values retrieved from S&P Global were unavailable due to mapping limitations.
Key Takeaways for Investors
- Strategic alternatives review is a central catalyst; management indicates “advanced stages,” raising the probability of value-realizing transactions (asset sales or partnership-level) .
- 2024 setup is constructive despite gas price headwinds: adjusted EBITDA guidance of $260–$300M, with visible drivers from DJ synergies, Utica compression fees, and Double E contractual increases .
- Double E pipeline continues to strengthen: q/q throughput up 18% to 386 MMcf/d in Q4 and a new 10-year take-or-pay contract tied to the 300 MMcf/d Janus Plant — a medium-term volume and EBITDA lever .
- Operational momentum persists: 77 Q4 well connects, five rigs, and >140 DUCs support throughput growth into 2024, especially in Rockies and Barnett .
- Balance sheet/liquidity manageable with covenant headroom, but leverage remains elevated (~5.4x); interest expense is a GAAP headwind — watch refinancing dynamics amid strategic outcomes .
- Non-GAAP reconciliation items are material: loss on early extinguishment of debt ($10.9M) and high interest expense shape GAAP net loss; adjusted EBITDA and DCF better reflect ongoing operations .
- Near-term trading: headline sensitivity to strategic review updates; medium-term thesis hinges on execution vs 2024 guidance and continued Double E/OGC commercialization .